FDA label
What is Eucrisa used for?
Eucrisa contains crisaborole. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “EUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Eucrisa?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Eucrisa, ointment
Indications and Usage, quoted from the label by Pfizer Laboratories Div Pfizer Inc (NDA207695). Cross-references to other label sections are left out.
EUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
Source: DailyMed label, set id 609b77de-1ca3-4783-b8f5-01a9c0f1d77d, version 13, effective September 23, 2025. NDC 55724-211, one of 1 listing for this product.
Questions
What is Eucrisa used for?
The FDA label says: “EUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.”
What drug class is Eucrisa?
FDA lists crisaborole in the Phosphodiesterase 4 Inhibitor established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.